CEA-Antigen and SCC-Antigen mRNA Expression in Peripheral Blood Predict Hematogenous Recurrence After Resection in Patients with Esophageal Cancer
Koji Tanaka(Mie University), Osamu Ishikawa(Gunma University), Masaaki Motoori(Osaka International Cancer Institute), Masayuki Ohue(Hyogo Medical University), Isao Miyashiro(Osaka International Cancer Institute), Yuichiro� Doki(Osaka Gakuin University), Hiroaki Ohigashi(Teine Keijinkai Hospital), Hidenori Takahashi(Osaka International Cancer Institute), Takashi Yamamoto(Koga Hospital), Terumasa Yamada, Kentaro Kishi(Osaka International Cancer Institute), Kunihito Gotoh(Osaka International Cancer Institute), Tomoyuki Yamasaki(Osaka International Cancer Institute), Tatsushi Shingai(Kinki Central Hospital), Shingo Noura(Osaka Rosai Hospital), Masahiko Yano(Nagoya Sangyo University)
Cited by 40
Related Papers
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
|NEJM Evidence|2022|1.1k
Practical Usefulness of Lymphatic and Connective Tissue Clearance for the Carcinoma of the Pancreas Head
|Annals of Surgery|1988|373
Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice.
|PubMed|2000|334
Correlation of CD133, OCT4, and SOX2 in Rectal Cancer and Their Association with Distant Recurrence After Chemoradiotherapy
|Annals of Surgical Oncology|2009|324